Comparison of Endoscopic and Open Surgery for Gynecomastia
12. Juni 2026 aktualisiert von: Antalya City Hospital
Prospective Comparative Evaluation of Different Surgical Techniques in the Treatment of Gynecomastia: A Multicenter Study
The goal of this observational study is to compare the clinical outcomes, safety, and patient satisfaction of endoscopic versus conventional open surgical techniques in adult male patients undergoing surgery for gynecomastia.
The main questions it aims to answer are:
- Does endoscopic gynecomastia surgery provide better aesthetic outcomes and patient satisfaction compared with conventional open surgery?
- Does endoscopic surgery reduce postoperative complications, sensory changes of the nipple-areola complex, and visible scarring compared with conventional open surgery?
Researchers will compare patients undergoing endoscopic nipple-areola complex-preserving mastectomy with patients undergoing conventional open nipple-areola complex-preserving mastectomy to evaluate differences in surgical outcomes, complications, cosmetic results, and quality of life.
Participants will:
- Undergo gynecomastia surgery as part of their routine clinical care using either an endoscopic or conventional open technique.
- Attend routine postoperative follow-up visits for up to 12 months.
- Complete patient-reported outcome assessments, including pain and satisfaction questionnaires.
- Undergo evaluation of scar quality, nipple-areola complex sensation, and postoperative complications during follow-up.
Studienübersicht
Status
Rekrutierung
Bedingungen
Studientyp
Beobachtungs
Einschreibung (Geschätzt)
100
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: MEHMET OLCUM
- Telefonnummer: +905388101828
- E-Mail: mehmetolcum@hotmail.com
Studieren Sie die Kontaktsicherung
- Name: MERVE TOKOCİN
- Telefonnummer: +905356235594
- E-Mail: mervetokocin@gmail.com
Studienorte
-
-
-
Antalya, Türkei (türkiye)
- Rekrutierung
- Antalya City Hospital
-
Kontakt:
- Mehmet Olcum, MD
- Telefonnummer: +905388101828
- E-Mail: mehmetolcum@hotmail.com
-
Istanbul, Türkei (türkiye)
- Rekrutierung
- Bagcilar Training and Research Hospital
-
Kontakt:
- Merve Tokocin, MD
- Telefonnummer: +905356235594
- E-Mail: mervetokocin@gmail.com
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Nein
Probenahmeverfahren
Nicht-Wahrscheinlichkeitsprobe
Studienpopulation
The study population consists of adult male patients with primary gynecomastia (Simon Grade II-III) who undergo surgical treatment at Antalya City Hospital and Istanbul Bagcilar Training and Research Hospital.
Participants will undergo either endoscopic or conventional open nipple-areola complex-preserving mastectomy as part of routine clinical care and will be followed for 12 months to evaluate clinical outcomes, complications, aesthetic results, sensory outcomes, patient satisfaction, and quality of life.
Beschreibung
Inclusion Criteria:
- Male patients aged 18 to 60 years.
- Clinically and/or ultrasonographically confirmed primary gynecomastia with palpable glandular tissue ≥2 cm.
- Simon Grade II or Grade III gynecomastia.
- Patients requesting surgical treatment because of cosmetic and/or psychosocial concerns.
- Eligible for either endoscopic or conventional open nipple-areola complex-preserving mastectomy according to routine clinical practice.
- Ability to provide written informed consent.
- Willingness and ability to comply with the 12-month follow-up schedule.
Exclusion Criteria:
- Secondary gynecomastia caused by endocrine disorders, medications, hypogonadism, thyroid disease, or suspected malignancy.
- Pseudogynecomastia (lipomastia without glandular proliferation).
- Age younger than 18 years or older than 60 years.
- Severe uncontrolled comorbidities that may increase surgical risk.
- Previous chest or breast surgery, chest irradiation, or significant chest trauma.
- Active infection or coagulation disorder.
- Immunodeficiency disorders.
- Inability to provide informed consent.
- Inability to complete the planned follow-up period.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Endoscopic NAC-Preserving Mastectomy Cohort
Adult male patients with gynecomastia undergoing endoscopic nipple-areola complex-preserving mastectomy as part of routine clinical care.
Participants will be followed for 12 months to assess postoperative complications, nipple-areola complex sensation, scar quality, patient satisfaction, and quality of life.
|
The procedure is performed under general anesthesia using a minimally invasive endoscopic approach.
Breast glandular tissue is removed through a small axillary incision while preserving the nipple-areola complex.
Liposuction may be performed when clinically indicated.
The surgical technique is performed as part of routine clinical care and is not assigned by the study.
|
|
Conventional Open NAC-Preserving Mastectomy Cohort
Adult male patients with gynecomastia undergoing conventional open nipple-areola complex-preserving mastectomy as part of routine clinical care.
Participants will be followed for 12 months to assess postoperative complications, nipple-areola complex sensation, scar quality, patient satisfaction, and quality of life
|
The procedure is performed under general anesthesia using a conventional open surgical approach.
Breast glandular tissue is removed through a periareolar incision while preserving the nipple-areola complex.
Liposuction may be performed when clinically indicated.
The surgical technique is performed as part of routine clinical care and is not assigned by the study.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Patient Satisfaction
Zeitfenster: From enrollment through the 12-month follow-up period
|
Patient satisfaction assessed using the BODY-Q Chest Module following gynecomastia surgery
|
From enrollment through the 12-month follow-up period
|
|
Overall Postoperative Complication Rate
Zeitfenster: From enrollment through the 12-month follow-up period
|
Incidence of postoperative complications including nipple-areola complex hypoesthesia, wound complications, hematoma, seroma, infection, contour deformity, and need for revision surgery
|
From enrollment through the 12-month follow-up period
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Scar Quality
Zeitfenster: From enrollment to the end of follow-up at 12 months
|
Scar quality assessed using the Vancouver Scar Scale (VSS)
|
From enrollment to the end of follow-up at 12 months
|
|
Nipple-Areola Complex Sensation
Zeitfenster: From enrollment to the end of follow-up at 12 months
|
Sensory function of the nipple-areola complex assessed using the Semmes-Weinstein Monofilament Test (SWMT)
|
From enrollment to the end of follow-up at 12 months
|
|
Postoperative Pain
Zeitfenster: From enrollment to the end of follow-up at 12 months
|
Patient-reported pain assessed using the Visual Analog Scale (VAS)
|
From enrollment to the end of follow-up at 12 months
|
|
Revision Surgery Rate
Zeitfenster: From enrollment to the end of follow-up at 12 months
|
Incidence of revision surgical procedures required after the initial operation
|
From enrollment to the end of follow-up at 12 months
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
8. Januar 2026
Primärer Abschluss (Geschätzt)
8. Januar 2027
Studienabschluss (Geschätzt)
8. Januar 2028
Studienanmeldedaten
Zuerst eingereicht
12. Juni 2026
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
12. Juni 2026
Zuerst gepostet (Tatsächlich)
17. Juni 2026
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
17. Juni 2026
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
12. Juni 2026
Zuletzt verifiziert
1. Mai 2026
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 175/2025
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
UNENTSCHIEDEN
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .